J&J HAS ENTERED STRATEGIC AGREEMENTS WITH SAIL BIOMEDICINES, WINNING AN EXCLUSIVE OPTION TO ACQUIRE THE COMPANY FOR $2.58 BLN ALONG WITH AN
J&J HAS ENTERED STRATEGIC AGREEMENTS WITH SAIL BIOMEDICINES, WINNING AN EXCLUSIVE OPTION TO ACQUIRE THE COMPANY FOR $2.58 BLN ALONG WITH AN EQUITY INVESTMENT, WITH TOTAL INITIAL PAYMENTS OF $785 MLN - SEC FILING
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.